Results 231 to 240 of about 132,537 (302)

Neurodevelopmental variations cascading from age 10 months to 3 years leading to attention‐deficit hyperactivity disorder/autism traits at age 9 in a general population

JCPP Advances, Volume 6, Issue 2, June 2026.
Associations of neurodevelopmental measures (Z‐scores of gross motor, visual reception, fine motor, receptive language, expressive language) at ages 10, 14, 18, 24, 32, and 40 months with (a) attention‐deficit/hyperactivity disorder trait, (b) autism spectrum disorder trait, (c) developmental coordination disorder trait, and (d) intellectual ...
Kenji J. Tsuchiya, Nagahide Takahashi, Yoko Nomura, Jeffrey H. Newcorn, Shigenobu Toda, Yuuka Ishikawa‐Omori, Akemi Okumura, Mohammad Shafiur Rahman, Toshiki Iwabuchi, Taeko Harada, Ikue Hirata, Chikako Nakayasu, Yuko Amma, Haruka Suzuki, Tomoko Nishimura   +14 more
wiley   +1 more source

MAPK ERK5 is a novel regulator of MHC-I in cancer cells. [PDF]

Cell Commun Signal
Viñas-Casas M, Lizcano JM.
europepmc   +1 more source

Doxorubicin induces ferroptosis in endometrial cancer by suppressing the MKK6/p38/CEBPB axis. [PDF]

J Transl Med
Zhang J, Wang Z, Li Y, Zhao P, Ren D, Lu X.   +5 more
europepmc   +1 more source

Quantitative Measurement of Extracellular Vesicle‐Sized Particles in Blood Plasma by Laser Diffraction Without an Extraction Process: A Proof‐of‐Concept Study in Atrial Fibrillation

Journal of Arrhythmia, Volume 42, Issue 3, June 2026.
Laser diffraction enabled rapid measurement of extracellular vesicle‐sized particles in fasting plasma without an extraction process. In this proof‐of‐concept study, particle concentrations were higher in atrial fibrillation than in controls, suggesting the potential of this simple approach for biomarker assessment.
Giichi Nitta, Kotone Tatsumi, Nurjahon Ummatalieva, Suzuka Ishikawa, Satomi Hamada, Anna Suzuki, Rina Iwasaki, Kohei Kawajiri, Ryutaro Kobayashi, Junji Yamaguchi, Ryunosuke Ohkawa, Kotaro Yoshioka, Tetsuya Nagata, Takanori Yokota, Kensuke Ihara, Tetsuo Sasano   +15 more
wiley   +1 more source

Activity-Selectivity of Flavonoid Derivatives in Endometriotic Cells. [PDF]

ACS Omega
Gomes KS, Coelho JA, Tesser PEH, Souza DCS, Silva ML, Ferreira EA, Lago JHG, Cerchiaro G.   +7 more
europepmc   +1 more source

Current Topics of Progressive Cardiac Conduction Disease

Journal of Arrhythmia, Volume 42, Issue 3, June 2026.
Many genes and the protein cause PCCD. Mutation of NaV1.5 or CX40 cause isolated PCCD, but mutation of lamin A/C, emerin, or desmin lead to cardiomyopathy, and PCCD. Mutation of transcription factor NCX2‐5, and Tbx5 associated with atrial septal defect and abnormal development of conduction system.
Naokata Sumitomo, Hitoshi Mori, Takashi Kumamoto, Taisuke Ishikawa, Akiko Seki, Naomasa Makita, Jean‐Jacques Schott, Arthur A. M. Wilde   +7 more
wiley   +1 more source

Omission of axillary dissection in patients with microscopic residual nodal disease after neoadjuvant chemotherapy. [PDF]

Gland Surg
Noguchi M, Inokuchi M, Morioka E, Haba Y.   +3 more
europepmc   +1 more source

Impact of Frequent Immune‐Mediated Adverse Events on Treatment Continuity and Outcomes During Durvalumab Plus Tremelimumab Therapy for Unresectable Hepatocellular Carcinoma

Liver International Communications, Volume 7, Issue 2, June 2026.
ABSTRACT Durvalumab plus tremelimumab (Dur/Tre) is the first‐line treatment for unresectable hepatocellular carcinoma (uHCC). Immune‐mediated adverse events (imAEs) are common; however, the impact of specific imAE types on treatment persistence and outcomes remains unclear.
Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Hideko Ohama, Fujimasa Tada, Shinichiro Nakamura, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Kazunari Tanaka, Takanori Matsuura, Yoshihide Ueda, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada, on behalf of the RELPEC Group and HCC 48 Group   +53 more
wiley   +1 more source

FBXW7 mutations reprogram glucose metabolism by activating the ETV6-GLUT1 axis. [PDF]

Mol Cancer
Fei S, Xu X, Wang T, Jiang X, Zhu H, Chen Y, Yuan R, Lv Z, Gao Z, Liu H, Chen X, Wang C, Gao K.   +12 more
europepmc   +1 more source

Discussion on Ishikawa's Lecture

JOURNAL OF THE ILLUMINATING ENGINEERING INSTITUTE OF JAPAN, 1923
openaire   +2 more sources